New Century Healthcare Reports 26.8% Revenue Decline, RMB41.1 Million Loss for H1 2025

Reuters
2025/08/27
<a href="https://laohu8.com/S/NCRE">New Century</a> Healthcare Reports 26.8% Revenue Decline, RMB41.1 Million Loss for H1 2025

New Century Healthcare Holding Co. Ltd. reported its interim results for the six months ended June 30, 2025. The company recorded a revenue of RMB304.5 million, reflecting a 26.8% year-on-year decrease compared to the same period last year. Revenue from medical services was RMB301.0 million, a 27.0% decline, with pediatric services experiencing a 29.2% drop to RMB255.7 million, comprising 85.0% of the total medical services revenue. The number of pediatric outpatient visits decreased by 25.6% to 88,045. The company reported a loss before income tax of RMB41.1 million, contrasting a profit before income tax of RMB72.2 million in the same period of 2024. This loss was primarily due to a revenue decrease of RMB111.5 million and impairment losses of RMB33.7 million on certain goodwill and property, plant, and equipment. Revenue from outpatient medical services decreased by 25.4% to RMB182.5 million, while inpatient revenue declined by 29.3% to RMB102.8 million. No dividend was declared or paid to Beijing Children's Hospital, Capital Medical University, a non-controlling shareholder of Beijing New Century Children's Hospital Co., Ltd., a subsidiary of the Group.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. New Century Healthcare Holding Co. Ltd. published the original content used to generate this news brief on August 27, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10